scPharmaceuticals (SCPH) PT Raised to $18 at H.C. Wainwright
Tweet
Share
E-mailGet Alerts SCPH Hot Sheet
Price: $5.67 --0%
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 5 | New: 5
Rating Summary:
4 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 1 | Down: 5 | New: 5
Join SI Premium – FREE
H.C. Wainwright analyst Douglas Tsao raised the price target on scPharmaceuticals (NASDAQ: SCPH) to $18.00 (from $15.00) while maintaining a Buy rating.
You May Also Be Interested In
- Citi Downgrades Lend Lease Group (LLC:AU) (LLESY) to Neutral
- Genesis Minerals Ltd (GMD:AU) PT Lowered to AUD8.60 at Citi
- Regis Resources Ltd. (RRL:AU) (RGRNF) PT Lowered to AUD7.40 at Citi
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
